Impact of cardiovascular counseling and screening in Hodgkin lymphoma survivors.
暂无分享,去创建一个
H. Putter | M. Schalij | A. Scholte | M. D. de Graaf | A. de Roos | L. V. van de Poll-Franse | C. Creutzberg | L. Daniëls | S. Krol | M. B. van T' Veer | M. B. van 't Veer
[1] K. Harmon,et al. SCREENING FOR SUDDEN CARDIAC DEATH IN ATHLETES: THE PSYCHOLOGICAL IMPACT OF BEING DIAGNOSED WITH POTENTIALLY LETHAL DISEASE , 2014, British Journal of Sports Medicine.
[2] J. Prutkin,et al. CARDIOVASCULAR SCREENING IN NCAA ATHLETES: FINDINGS FROM A MULTICENTER ECG-INCLUSIVE PROGRAM , 2014, British Journal of Sports Medicine.
[3] H. Putter,et al. Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptance†. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] Jeroen J. Bax,et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.
[5] F. Mols,et al. Illness perceptions in cancer survivors: what is the role of information provision? , 2013, Psycho-oncology.
[6] H. Amthauer,et al. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial , 2012, The Lancet.
[7] B. Rensing,et al. Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease. , 2011, Cancer treatment reviews.
[8] A. LaCasce,et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. , 2011, Blood.
[9] P. Fayers,et al. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] W. Chie,et al. An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients. , 2010, European journal of cancer.
[11] R. Greil,et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. , 2010, The New England journal of medicine.
[12] A. Varan,et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] R. Steingart,et al. Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. , 2008, AJR. American journal of roentgenology.
[14] A. Hart,et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. , 2007, Blood.
[15] A. Horwich,et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. , 2007, Journal of the National Cancer Institute.
[16] S. Hancock,et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] H. Michielsen,et al. Psychometric qualities of the Fatigue Assessment Scale in Croatian sarcoidosis patients. , 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[18] M. Eisemann,et al. Development of a questionnaire to evaluate the information needs of cancer patients: the EORTC questionnaire. , 2004, Patient education and counseling.
[19] S. Lipsitz,et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] H. Bartelink,et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] G. Norman,et al. Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.
[22] G. V. van Heck,et al. Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. , 2003, Journal of psychosomatic research.
[23] A. Hagenbeek,et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] van den Wim Heuvel,et al. Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. , 1997, Journal of epidemiology and community health.
[25] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.